U.S. President Donald Trump has signed an executive order directing federal agencies to loosen regulations on marijuana, a move that could mark one of the most significant changes in U.S. cannabis policy in decades. The order instructs the attorney general to move quickly toward reclassifying marijuana under the Controlled Substances Act, potentially shifting it from Schedule I to Schedule III.
If reclassified, marijuana would be grouped with drugs such as certain painkillers, ketamine, and testosterone, which are considered to have accepted medical uses and lower abuse potential. While marijuana would remain illegal at the federal level, the change could dramatically reshape the cannabis industry by expanding medical research opportunities, improving access to funding, and easing barriers for banks and institutional investors.
Trump defended the decision by emphasizing patient needs, saying many Americans suffering from chronic pain have pushed for greater access to marijuana-based treatments. Although he reiterated that he does not personally use the drug and remains cautious about controlled substances, he acknowledged its growing demand and medical relevance.
The move drew mixed reactions in Washington. Senate Democratic Leader Chuck Schumer welcomed the order, calling it a step toward long-overdue reform. In contrast, dozens of Republican lawmakers urged Trump not to proceed, arguing that reclassification could send the wrong message to children, empower drug cartels, and increase safety risks on U.S. roads.
Industry experts noted that congressional action would still be required to establish stable nationwide cannabis regulations. The Drug Enforcement Administration must now review the recommendation, a process that has historically been slowed by bureaucracy. Even with reclassification, marijuana would still face federal restrictions and criminal penalties.
Cannabis stocks initially rose on the news but later fell as investors realized the order did not include provisions for cannabis banking reform. Limited access to traditional financing remains a major challenge for marijuana companies, contributing to high operating costs and the persistence of black-market activity.
Public opinion continues to favor legalization, with most Americans supporting broader reform. Combined with previous efforts, including reviews initiated under former President Joe Biden, Trump’s order signals a continued shift toward easing long-standing federal marijuana policies while leaving the final outcome uncertain.


Trump Administration Defends Anthropic AI Restrictions in Ongoing Federal Lawsuit
Lebanese President Urges Israel to Negotiate End to Conflict, Calls Military Approach Ineffective
Trump Urges Restraint as Israel-Iran Tensions Threaten Fragile Peace Talks
Brazil Struggles to Stop Illegal Amazon Gold Mining as Gold Prices Surge
Canada-Indonesia Trade Pact Gains Momentum as Carney and Prabowo Discuss Economic Cooperation
Trump Forced Labour Tariff Plan Faces Criticism as Experts Question Effectiveness
ASIC Launches Formal Investigation Into KPMG Australia Partners Over Client Data Misuse Allegations
US Sanctions Cuban President Miguel Diaz-Canel and Key Officials Amid Rising Tensions
ICC Prosecutor Karim Khan Suspended as Member States Consider Removal
Taiwan Simulates Repelling Chinese Invasion in Major Coastal Live-Fire Exercise
US Expands Iran Sanctions, Targets Major Crypto Exchanges and Individuals
FIFA Faces Investigation Over 2026 World Cup Ticket Pricing and Seat Allocation Issues
Peru Presidential Election Too Close to Call as Ipsos Quick Count Shows Statistical Tie
Mauritius Rejects Report of Trump Administration Plan to Buy Chagos Islands
Meta Challenges Australia’s Proposed Tech Tax, Citing U.S. Trade Agreement Concerns
US Quantum Stocks Surge After $2 Billion Government Investment
Zelenskiy Praises Positive Talks With U.S. Envoys as Ukraine Peace Efforts Regain Momentum 



